Radiofrequency
OtherClosureFAST
Other names: ClosureFAST
NCT Number: NCT02080013
our aim is to compare early outcomes following EVL 1320 nm and segmental RF in a randomized study.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Endovenous Radiofrequency versus Laser Ablation for the Treatment of Great Saphenous Vein Reflux
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ClosureFAST
Other names: ClosureFAST
Time frame: 30 days
Ain Shams University
Other
Prospective, Randomized Study of Endovenous Segmental Radiofrequency Versus 1320 nm Laser Ablation for the Treatment of Great Saphenous Vein Reflux (RVLAb Study)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07514000
Cardiovascular Diseases, Radiofrequency Ablation
Zonguldak, Turkey (Türkiye)
View Trial DetailsNCT04054440
Arterial Occlusive Diseases, Arterio-venous Fistula
Dallas, Texas, United States
View Trial DetailsNCT06667570
Cardiovascular Diseases, Hyperpigmentation
São Paulo, Brazil
View Trial DetailsNCT05650073
Cardiovascular Diseases, Varicose Veins
Phoenix, Arizona, United States
View Trial Details